Lipoprotein-associated phospholipase A(2), inflammatory biomarkers, and risk of cardiovascular disease in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)

M.J. Caslake, C.J. Packard, M. Robertson, J. Cooney, J.J. Nelson, I. Ford, Allan Gaw, J.W. Jukema, P.W. Macfarlane, D.J. Stott, J. Shepherd

Research output: Contribution to journalArticlepeer-review

23 Citations (Scopus)

Abstract

Objective: Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) is an inflammatory biomarker that circulates mainly bound to LDL. We evaluated the association of Lp-PLA(2) with vascular events in the elderly where the importance of LDL is diminished as a risk factor for coronary disease.
Original languageEnglish
Pages (from-to)28-34
Number of pages7
JournalAtherosclerosis
Volume210
Issue number1
DOIs
Publication statusPublished - May 2010

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Lipoprotein-associated phospholipase A(2), inflammatory biomarkers, and risk of cardiovascular disease in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)'. Together they form a unique fingerprint.

Cite this